drugset / Trial / NCT01202266
A Multiple Dose Study Of PF-05161704 In Healthy Volunteers
RandomizedParallel-groupDouble-blindBasic science
Summary
The primary purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of multiple escalating oral doses of PF-05161704 in healthy volunteers
Timeline
- Start
- 2010-08
- Primary completion
- 2010-12
- Completion
- 2010-12
Outcome
Outcome not reported
Stopped: “The study was terminated on October 29, 2010 due to gastrointestinal adverse events.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-05161704 | Unknown | 5 mg | Oral |
| Subject | PF-05161704 | Unknown | 15 mg | Oral |
| Subject | PF-05161704 | Unknown | 50 mg | Oral |
| Subject | PF-05161704 | Unknown | 150 mg | Oral |